Literature DB >> 25714677

Peripheral insulin resistance in obese girls with hyperandrogenism is related to oxidative phosphorylation and elevated serum free fatty acids.

Melanie Cree-Green1, Bradley R Newcomer2, Gregory Coe3, Lindsey Newnes3, Amy Baumgartner3, Mark S Brown4, Laura Pyle5, Jane E Reusch6, Kristen J Nadeau7.   

Abstract

Hyperandrogenic syndrome (HAS) is associated with insulin resistance (IR) and type 2 diabetes. Muscle IR in type 2 diabetes is linked with defects in mitochondrial oxidative capacity. In vivo muscle mitochondrial function has not been studied in HAS, especially in youth, who are early in the disease process. Our goal was to measure muscle mitochondrial oxidative function and peripheral IR in obese youth with HAS. Obese girls without HAS [n = 22, age 15(13,17) yr, BMI Z-score 2.05 ± 0.37] and with HAS [n = 35, age 15(14,16) yr, BMI Z-score 2.18 ± 0.30] were enrolled. Mitochondrial function was assessed with (31)phosphorus MR spectroscopy before, during, and after near-maximal isometric calf exercise, and peripheral IR was assessed with an 80 mU·m(-2)·min(-1) hyperinsulinemic euglycemic clamp. Girls with HAS had higher androgens [free androgen index 7.9(6.6,15.5) vs. 3.5(3.0,4.0), P < 0.01] and more IR [glucose infusion rate 9.4(7.0, 12,2) vs. 14.5(13.2,15.8) mg·kg lean(-1)·min(-1), P < 0.01]. HAS girls also had increased markers of inflammation including CRP, platelets, and white blood cell count and higher serum free fatty acids during hyperinsulinemia. Mitochondrial oxidative phosphorylation was lower in HAS [0.11(0.06,0.19) vs. 0.18(0.12,0.23) mmol/s, P < 0.05], although other spectroscopy markers of mitochondrial function were similar between groups. In multivariate analysis of the entire cohort, IR related to androgens, oxidative phosphorylation, and free fatty acid concentrations during hyperinsulinemia. These relationships were present in just the HAS cohort as well. Obese girls with HAS have significant peripheral IR, which is related to elevated androgens and free fatty acids and decreased mitochondrial oxidative phosphorylation. These may provide future options as targets for therapeutic intervention.

Entities:  

Keywords:  hyperandrogenic syndrome; hyperandrogenism; insulin resistance; mitochondria; obesity

Mesh:

Substances:

Year:  2015        PMID: 25714677      PMCID: PMC4420897          DOI: 10.1152/ajpendo.00619.2014

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  57 in total

1.  31P MRS measurement of mitochondrial function in skeletal muscle: reliability, force-level sensitivity and relation to whole body maximal oxygen uptake.

Authors:  D E Larson-Meyer; B R Newcomer; G R Hunter; H P Hetherington; R L Weinsier
Journal:  NMR Biomed       Date:  2000-01       Impact factor: 4.044

2.  Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls.

Authors:  Christopher R McCartney; Susan K Blank; Kathleen A Prendergast; Sandhya Chhabra; Christine A Eagleson; Kristin D Helm; Richard Yoo; R Jeffrey Chang; Carol M Foster; Sonia Caprio; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2006-11-21       Impact factor: 5.958

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Skeletal muscle mitochondrial function in polycystic ovarian syndrome.

Authors:  Rasmus Rabøl; Pernille F Svendsen; Mette Skovbro; Robert Boushel; Peter Schjerling; Lisbeth Nilas; Sten Madsbad; Flemming Dela
Journal:  Eur J Endocrinol       Date:  2011-07-28       Impact factor: 6.664

5.  Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women.

Authors:  A Corbould
Journal:  J Endocrinol       Date:  2007-03       Impact factor: 4.286

6.  Intact primary mitochondrial function in myotubes established from women with PCOS.

Authors:  Mette Brandt Eriksen; Ariane Denise Minet; Dorte Glintborg; Michael Gaster
Journal:  J Clin Endocrinol Metab       Date:  2011-05-18       Impact factor: 5.958

7.  Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.

Authors:  Dorte Glintborg; Marianne Andersen; Claus Hagen; Jan Frystyk; Veronica Hulstrøm; Allan Flyvbjerg; Anne Pernille Hermann
Journal:  Eur J Endocrinol       Date:  2006-08       Impact factor: 6.664

8.  Method for controlled mitochondrial perturbation during phosphorus MRS in children.

Authors:  Melanie Cree-Green; Bradley R Newcomer; Mark Brown; Amber Hull; Amy D West; Debra Singel; Jane E B Reusch; Kim McFann; Judith G Regensteiner; Kristen J Nadeau
Journal:  Med Sci Sports Exerc       Date:  2014-10       Impact factor: 5.411

9.  Effects of methyltestosterone on insulin secretion and sensitivity in women.

Authors:  M P Diamond; D Grainger; M C Diamond; R S Sherwin; R A Defronzo
Journal:  J Clin Endocrinol Metab       Date:  1998-12       Impact factor: 5.958

10.  Induction of insulin resistance by androgens and estrogens.

Authors:  K H Polderman; L J Gooren; H Asscheman; A Bakker; R J Heine
Journal:  J Clin Endocrinol Metab       Date:  1994-07       Impact factor: 5.958

View more
  26 in total

1.  Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance.

Authors:  Melanie Cree-Green; Pattara Wiromrat; Jacob J Stuppy; Jessica Thurston; Bryan C Bergman; Amy D Baumgartner; Samantha Bacon; Ann Scherzinger; Laura Pyle; Kristen J Nadeau
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-12-18       Impact factor: 4.310

2.  Eigenvector metabolite analysis reveals dietary effects on the association among metabolite correlation patterns, gene expression, and phenotypes.

Authors:  Clare H Scott Chialvo; Ronglin Che; David Reif; Alison Motsinger-Reif; Laura K Reed
Journal:  Metabolomics       Date:  2016-09-20       Impact factor: 4.290

Review 3.  Cardiometabolic risk in obese children.

Authors:  Stephanie T Chung; Anthony U Onuzuruike; Sheela N Magge
Journal:  Ann N Y Acad Sci       Date:  2018-01       Impact factor: 5.691

4.  Youth With Type 1 Diabetes Have Adipose, Hepatic, and Peripheral Insulin Resistance.

Authors:  Melanie Cree-Green; Jacob J Stuppy; Jessica Thurston; Bryan C Bergman; Gregory V Coe; Amy D Baumgartner; Samantha Bacon; Ann Scherzinger; Laura Pyle; Kristen J Nadeau
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

5.  Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome.

Authors:  Melanie Cree-Green; Anne-Marie Carreau; Haseeb Rahat; Yesenia Garcia-Reyes; Bryan C Bergman; Laura Pyle; Kristen J Nadeau
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-02-12       Impact factor: 4.310

6.  Insulin resistance in type 2 diabetes youth relates to serum free fatty acids and muscle mitochondrial dysfunction.

Authors:  Melanie Cree-Green; Abhinav Gupta; Gregory V Coe; Amy D Baumgartner; Laura Pyle; Jane E B Reusch; Mark S Brown; Bradley R Newcomer; Kristen J Nadeau
Journal:  J Diabetes Complications       Date:  2016-10-17       Impact factor: 2.852

7.  Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS-HS index).

Authors:  Anne-Marie Carreau; Laura Pyle; Yesenia Garcia-Reyes; Haseeb Rahat; Tim Vigers; Thomas Jensen; Ann Scherzinger; Kristen J Nadeau; Melanie Cree-Green
Journal:  Clin Endocrinol (Oxf)       Date:  2019-08-16       Impact factor: 3.478

8.  Hepatic Steatosis is Common in Adolescents with Obesity and PCOS and Relates to De Novo Lipogenesis but not Insulin Resistance.

Authors:  Melanie Cree-Green; Bryan C Bergman; Gregory V Coe; Lindsey Newnes; Amy D Baumgartner; Samantha Bacon; Ann Sherzinger; Laura Pyle; Kristen J Nadeau
Journal:  Obesity (Silver Spring)       Date:  2016-11       Impact factor: 5.002

9.  Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Julia D Phan; Karen L Leung; Tristan R Grogan; Xiangmiang Ding; Xinmin Li; Luis R Hoyos; David H Abbott; Gregorio D Chazenbalk
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

Review 10.  Developmental programming of insulin resistance: are androgens the culprits?

Authors:  Muraly Puttabyatappa; Robert M Sargis; Vasantha Padmanabhan
Journal:  J Endocrinol       Date:  2020-06       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.